Abstract
Matrix metalloproteinase (MMP) promoter polymorphisms are considered to play roles in the aetiology of endometriosis and adenomyosis, however, the evidence available are inconsistent. We aimed to systematically review the asscociation between MMP-1 -1607 1G/2G MMP-2 -735 C/T, MMP-3 -1171 5A/6A and MMP-9 -1562 C/T polymorphisms and the risk of endometriosis and adenomyosis. A systemic search was conducted in Ovid, PubMed, Chinese National Knowledge Infrastructure and Chinese Wanfang Database. We used the pooled odds ratio (OR) and their corresponding 95% confidence interval (CI) to calculate the statistical power. Besides, we evaluated the quality of individual studies based on Newcastle–Ottawa scale. A total of 13 papers with 18 studies conformed to our inclusion criteria. We observed a significant association between MMP-1 -1607 1G/2G polymorphism and the susceptibility of endometriosis and adenomyosis under recessive model (OR = 1.25, 95%CI = 1.03–1.53, P= 0.03). While no significant association was found in MMP-2 -735 C/T, MMP-3 -1171 5A/6A and MMP-9 -1562 C/T polymorphisms. This systemic review and meta-analysis suggested that theMMP-1 -1607 1G/2G polymorphism might play an important role in the risk of endometriosis and adenomyosis. Further, more well-designed and large-scale studies regarding gene–gene and gene–environment interactions are needed in the future.
Similar content being viewed by others
References
Birkedal-Hansen H. 1995 Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7, 728–735.
Borghese B., Chiche J. D., Vernerey D., Chenot C., Mir O., Bijaoui G. et al. 2008 Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression. Hum. Reprod. 23, 1207–1213.
Chen Y., Nixon N. B., Dawes P. T. and Mattey D. L. 2012 Influence of variations across the MMP-1 and -3 genes on the serum levels of MMP-1 and -3 and disease activity in rheumatoid arthritis. Genes Immun. 13, 29–37.
Cox K. E., Piva M. and Sharpe-Timms K. L. 2001 Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol. Reprod. 65, 1297–1303.
DerSimonian R. and Laird N. 1986 Meta-analysis in clinical trials. Control. Clin. Trials 7, 177–188.
Egger M., Davey Smith G., Schneider M. and Minder C. 1997 Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634.
Gilabert-Estelles J., Estelles A., Gilabert J., Castello R., Espana F., Falco C. et al. 2003 Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum. Reprod. 18, 1516–1522.
Giudice L. C. and Kao L. C. 2004 Endometriosis. Lancet 364, 1789–1799.
Gonzales M., de Matos L., da Costa Gonçalves M., Blasbalg R., Dias Junior J., Podgaec S. et al. 2012 Patients with adenomyosis are more likely to have deep endometriosis. Gynecol. Surg. 9, 259–264.
Guo S. W. 2009 Epigenetics of endometriosis. Mol. Hum. Reprod. 15, 587–607.
Han Y. J., Kim H. N., Yoon J. K., Yi S. Y., Moon H. S., Ahn J. J. et al. 2009 Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced-stage endometriosis. Fertil. Steril. 91, 2324–2330.
Higgins J. P., Thompson S. G., Deeks J. J. and Altman D. G. 2003 Measuring inconsistency in meta-analyses. BMJ 327, 557–560.
Jichan N., Xishi L. and Guo S. W. 2010 Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod. Sci. 17, 995–1005.
Kang S., Wang Y., Zhang J. H., Jin X., Fang S. M. and Li Y. 2005 Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis. Zhonghua Fu Chan Ke Za Zhi 40, 601–604.
Kang S., Zhao X., Xing H., Wang N., Zhou R., Chen S. et al. 2008a Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis. Environ. Mol. Mutagen. 49, 226–231.
Kang S., Zhao X. W., Wang N., Chen S. C., Zhou R. M. and Li Y. 2008b Association of polymorphisms of the MMP-2 and TIMP-2 genes with the risk of endometriosis in North Chinese women. Fertil. Steril. 90, 2023–2029.
Kitawaki J., Obayashi H., Ishihara H., Koshiba H., Kusuki I., Kado N. et al. 2001 Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum. Reprod. 16, 51–55.
Kokorine I., Nisolle M., Donnez J., Eeckhout Y., Courtoy P. J. and Marbaix E. 1997 Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil. Steril. 68, 246–251.
Liu X. and Guo S. W. 2012 Aberrant immunoreactivity of deoxyribonucleic acid methyltransferases in adenomyosis. Gynecol. Obstet. Invest. 74, 100–108.
Liu X., Nie J. and Guo S. W. 2012 Elevated immunoreactivity against class I histone deacetylases in adenomyosis. Gynecol. Obstet. Invest. 74, 50–55.
Maddalena Ferrari M., Luisa Biondi M., Rossi G., Grijuela B., Gaita S., Perugino G. et al. 2006 Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis. Acta Obstet. Gynecol. Scand. 85, 212–217.
McCarty C. A., Berg R. L., Welter J. D., Kitchner T. E. and Kemnitz J. W. 2012 A novel gene-environment interaction involved in endometriosis. Int. J. Gynaec. Obstet. 116, 61–63.
Morosova E. B., Chukhlovin A. B., Kulagina N. V., Kipich N. V. and Totolian A. A. 2012 Functional gene polymorphism of matrix metalloproteinase-1 is associated with benign hyperplasia of myo- and endometrium in the Russian population. Genet. Test. Molc. Biomarkers 16, 1032–1037.
Nap A. W., Dunselman G. A., de Goeij A. F., Evers J. L. and Groothuis P. G. 2004 Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. Hum. Reprod. 19, 2180–2187.
Naphatthalung W. and Cheewadhanaraks S. 2012 Prevalence of endometriosis among patients with adenomyosis and/or myoma uteri scheduled for a hysterectomy. J. Med. Assoc. Thai. 95, 1136–1140.
Ozkan S., Murk W. and Arici A. 2008 Endometriosis and infertility: epidemiology and evidence-based treatments. Ann. N.Y. Acad. Sci. 1127, 92–100.
Pendas A. M., Santamaria I., Alvarez M. V., Pritchard M. and Lopez-Otin C. 1996 Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. Genomics 37, 266–268.
Pepper M. S. 2001 Role of the matrix metalloproteinase and plasminogen activator–plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104–1117.
Rutter J. L., Mitchell T. I., Buttice G., Meyers J., Gusella J. F., Ozelius L. J. et al. 1998 A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58, 5321–5325.
Saare M., Lamp M., Kaart T., Karro H., Kadastik U., Metspalu A. et al. 2010 Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis. Fertil. Steril. 94, 1560–1563.
Shan K., Lian-Fu Z., Hui D., Wei G., Na W., Xia J. et al. 2006 Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China. Mol. Hum. Reprod. 12, 35–39.
Shan K., Ying W., Jian-Hui Z., Wei G., Na W. and Yan L. 2005 The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China. Mol. Hum. Reprod. 11, 423–427.
Szamatowicz J., Laudanski P. and Tomaszewska I. 2002 Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum. Reprod. 17, 284–288.
Tong X., Li Z., Wu Y., Fu X., Zhang Y. and Fan H. 2014 COMT 158G/A and CYP1B1 432C/G polymorphisms increase the risk of endometriosis and adenomyosis: a meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 179, 17–21.
Trovó de Marqui A. B. 2012 Genetic polymorphisms and endometriosis: contribution of genes that regulate vascular function and tissue remodeling. Rev. Assoc. Med. Bras. 58, 620–632.
Wang Y. F., Qu Y. E. and Yang M. 2007 Polymorphism in MMP-9 gene promoter and genetic predisposition of endometriosis. Prog. Obstet. Gynecol. 16, 267–269.
Wells G. A., Shea B., O’Connell D., Peterson J., Welch V., Losos M. et al. 2011 The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Ottawa Health Research Institute, www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 1 October 2014.
Xing X., Tang Y. B., Yuan G., Wang Y., Wang J., Yang Y. et al. 2013 The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int. J. Cancer 132, 2589–2596.
Yang B., Fan S., Zhi X., Li Y., Liu Y., Wang D. et al. 2014 Associations of MTHFR gene polymorphisms with hypertension and hypertension in pregnancy: a meta-analysis from 114 studies with 15411 cases and 21970 controls. PLoS One 9, e87497.
Yang Y., Zhang J., Han Z. Y., Ma X., Hao Y. L., Xu C. T. et al. 2015 Ultrasound-guided percutaneous microwave ablation for adenomyosis: efficacy of treatment and effect on ovarian function. Sci. Rep. 5, 10034.
Yarmolinskaya M. I., Molotkov A. S., Bezhenar V. F., Shved N. Y., Ivaschenko T. E. and Baranov V. S. 2014 Matrix metalloproteinases’s association of polymorphisms of MMP3 and MMP9 with development of genital endometriosis. Russ. J. Genet. 50, 205–210.
Ye S. 2000 Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 19, 623– 629.
Yu C., Zhou Y., Miao X., Xiong P., Tan W. and Lin D. 2004 Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res. 64, 7622–7628.
Zhang B., Ye S., Herrmann S. M., Eriksson P., de Maat M., Evans A. et al. 1999 Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99, 1788–1794.
Zhou M., Guo R., Zeng X. H., Wang C. P., Luo Y. and Huang X. L. 2013 Correlation between promoter polymorphism of MMP-2 and susceptibility of endometriosis. J. Hainan Med. Univ. 19, 15–17.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ye H., He Y., Wang J., Song T., Lan Z., Zhao Y. and Xi M. 2016 Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis. J. Genet. 95, xx–xx
Hui Ye, Yazhou He and Jiarong Wang contributed equally to this work
Rights and permissions
About this article
Cite this article
YE, H., HE, Y., WANG, J. et al. Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis. J Genet 95, 611–619 (2016). https://doi.org/10.1007/s12041-016-0675-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-016-0675-5